DeepMed Research

QUEEN MARY UNIVERSITY OF LONDON

🇬🇧United Kingdom

Country: 🇬🇧United Kingdom

Ownership: Private

Established: 1882-01-08

Employees: 1K

Market Cap: -

Website: http://www.qmul.ac.uk

Clinical Trials

Preventing Preterm Birth With Probiotics

Not Applicable

Completed

Conditions: Preterm Birth

Interventions: Dietary Supplement: Probiotic
Other: Placebo Comparator

First Posted Date: 2016-02-26

Last Posted Date: 2017-09-20

Lead Sponsor: Queen Mary University of London

Target Recruit Count: 304

Registration Number: NCT02692820

Locations: 🇬🇧
Homerton University Hospital, London, United Kingdom
🇬🇧
Barts Health NHS Trust, London, United Kingdom

Telomere Biology and AKI in Cardiac Surgery

Completed

Conditions: Coronary Artery Disease
Acute Kidney Injury
Heart Valve Diseases

Interventions: Other: No intervention

First Posted Date: 2016-02-26

Last Posted Date: 2017-09-20

Lead Sponsor: Queen Mary University of London

Target Recruit Count: 254

Registration Number: NCT02692833

Locations: 🇬🇧
St Bartholomew's Hospital, London, United Kingdom

Short-term Preoperative Treatment With Enzalutamide, Alone or in Combination With Exemestane in Primary Breast Cancer

Phase 2

Completed

Conditions: Primary Breast Cancer ER+ve
Primary Breast Cancer AR+ve TNBN

Interventions: Drug: Enzalutamide
Drug: Exemestane

First Posted Date: 2016-02-09

Last Posted Date: 2024-07-05

Lead Sponsor: Queen Mary University of London

Target Recruit Count: 221

Registration Number: NCT02676986

Locations: 🇺🇸
MD Anderson Cancer Centre, Houston, Texas, United States
🇩🇪
Evangelische Kliniken Gelsenkirchen, Gelsenkirchen, Germany
🇩🇪
Evangelisches Waldkrankenhaus Spandau, Berlin, Germany

and more 38 locations

Preoperative MPDL3280A in Transitional Cell Carcinoma of the Bladder

Phase 2

Completed

Conditions: Bladder Cancer

Interventions: Drug: MPDL3280A

First Posted Date: 2016-01-25

Last Posted Date: 2025-03-10

Lead Sponsor: Queen Mary University of London

Target Recruit Count: 96

Registration Number: NCT02662309

Locations: 🇫🇷
Centre Hospitalier Universitaire (CHU) de Bordeaux, Bordeaux, France
🇫🇷
Hospices Civils de Lyon, Lyon, France
🇫🇷
Institut Claudius Régaud, Toulouse, France

and more 17 locations

Predictors of CIN Study Series 5.0:Stability Study in Vaginal Self-samples

Not Applicable

Completed

Conditions: Human Papillomavirus

Interventions: Other: Cervico-vaginal self-sample taken with first flocked swab
Other: Cervico-vaginal self-sample taken with a second flocked swab
Other: Cervico-vaginal self-sample taken with a HerSwab device

First Posted Date: 2015-12-07

Last Posted Date: 2023-06-15

Lead Sponsor: Queen Mary University of London

Target Recruit Count: 60

Registration Number: NCT02622997

Th17 Responses Evaluated in RA Patients on Inhibitors of TNFα

Completed

Conditions: Rheumatoid Arthritis

First Posted Date: 2015-12-02

Last Posted Date: 2022-09-26

Lead Sponsor: Queen Mary University of London

Target Recruit Count: 60

Registration Number: NCT02620189

Locations: 🇬🇧
University College London Hospitals NHS Foundation Trust, Rheumatology Department, London, United Kingdom
🇬🇧
Imperial College Healthcare NHS Trust, London, United Kingdom
🇬🇧
Cambridge University Hospitals NHS Foundation Trust, Addenbrooke's Hospital, Cambridge, United Kingdom

and more 5 locations

Implementing Treatment Algorithms for the Correction of Trauma Induced Coagulopathy

Phase 2

Completed

Conditions: Hemorrhage
Trauma
Coagulopathy

Interventions: Device: VHA algorithm

First Posted Date: 2015-11-01

Last Posted Date: 2018-08-29

Lead Sponsor: Queen Mary University of London

Target Recruit Count: 412

Registration Number: NCT02593877

Locations: 🇳🇴
Oslo University Hospital, Oslo, Norway
🇳🇱
Academic Medical Centre, Amsterdam, Netherlands
🇩🇰
Copenhagen University Hospital, Copenhagen, Denmark

and more 4 locations

A Study of AZD2014 in Combination With Selumetinib in Patients With Advanced Cancers

Phase 1

Conditions: Squamous Cell Lung Cancer
Non-squamous Cell Lung Cancer With KRAS Mutations
Non-squamous Cell Lung Cancer With Wild-type KRAS
Triple-Negative Breast Cancer

Interventions: Drug: AZD2014
Drug: AZD6244

First Posted Date: 2015-10-22

Last Posted Date: 2020-02-25

Lead Sponsor: Queen Mary University of London

Target Recruit Count: 118

Registration Number: NCT02583542

Locations: 🇬🇧
Christie NHS Foundation Trust, Manchester, United Kingdom
🇬🇧
University Hospitals Birmingham NHS Foundation Trust, Birmingham, United Kingdom
🇬🇧
University College London Hospitals NHS Foundation Trust, London, United Kingdom

and more 1 locations

Colonic Motility in Constipation and Ageing

Completed

Conditions: Ageing
Constipation

Interventions: Device: 3D-Transit system

First Posted Date: 2015-10-15

Last Posted Date: 2023-01-13

Lead Sponsor: Queen Mary University of London

Target Recruit Count: 50

Registration Number: NCT02575742

Locations: 🇬🇧
Queen Mary University of London, London, United Kingdom

Investigating the Effects of Dietary Nitrate on Vascular Function, Platelet Reactivity and Restenosis in Stable Angina

Phase 2

Active, not recruiting

Conditions: Cardiovascular Diseases

Interventions: Dietary Supplement: Beetroot Juice

First Posted Date: 2015-08-20

Last Posted Date: 2024-02-14

Lead Sponsor: Queen Mary University of London

Target Recruit Count: 300

Registration Number: NCT02529189

Locations: 🇬🇧
William Harvey Research Institute, Barts and The London School of Medicine, London, United Kingdom

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy